BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reuter SE, Faull RJ, Ranieri E, Evans AM. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients. Nephrol Dial Transplant. 2009;24:990-996. [PMID: 18987259 DOI: 10.1093/ndt/gfn588] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang YM, Zhuo L, Hu J, Cui G, Zhang L, Zhang XL, Li WG. Clinical significance of different carnitine levels for improving the prognosis of patients undergoing hemodialysis. Ren Fail 2016;38:1654-8. [PMID: 27758157 DOI: 10.1080/0886022X.2016.1229967] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Usui T, Zhao J, Fuller DS, Hanafusa N, Hasegawa T, Fujino H, Nomura T, Zee J, Young E, Robinson BM, Nangaku M. Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study. Nephrology (Carlton) 2021;26:46-53. [PMID: 32743932 DOI: 10.1111/nep.13765] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Murphy WJA, Steiber A, Connery GC, Carder J, Spry L, Hoppel C. Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation. Nephrology Dialysis Transplantation 2012;27:304-10. [DOI: 10.1093/ndt/gfr334] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
4 Higuchi T, Abe M, Mizuno M, Yamazaki T, Suzuki H, Moriuchi M, Oikawa O, Okawa E, Ando H, Okada K. Association of restless legs syndrome with oxidative stress and inflammation in patients undergoing hemodialysis. Sleep Medicine 2015;16:941-8. [DOI: 10.1016/j.sleep.2015.03.025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
5 Bene J, Csiky B, Komlosi K, Sulyok E, Melegh B. Dynamic adaptive changes of the serum carnitine esters during and after L-carnitine supplementation in patients with maintenance haemodialysis. Scandinavian Journal of Clinical and Laboratory Investigation 2011;71:280-6. [DOI: 10.3109/00365513.2011.560674] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
6 Malaguarnera M, Vacante M, Giordano M, Motta M, Bertino G, Pennisi M, Neri S, Malaguarnera M, Volti GL, Galvano F. L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol 2011; 17(39): 4414-4420 [PMID: 22110268 DOI: 10.3748/wjg.v17.i39.4414] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
7 Afzal M, Ali A, Sheikh N, Rafique S, Idrees M. Peripheral Expression of CXCL10 Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, and Ribavirin. J Interferon Cytokine Res 2020;40:301-9. [PMID: 32486887 DOI: 10.1089/jir.2019.0185] [Reference Citation Analysis]
8 Mercadal L, Coudert M, Vassault A, Pieroni L, Debure A, Ouziala M, Depreneuf H, Fumeron C, Servais A, Bassilios N, Bécart J, Assogba U, Allouache M, Bouali B, Luong N, Dousseaux MP, Tezenas-du Montcel S, Deray G. L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial. Clin J Am Soc Nephrol 2012;7:1836-42. [PMID: 22935844 DOI: 10.2215/CJN.12431211] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
9 Higuchi T, Abe M, Yamazaki T, Mizuno M, Okawa E, Ando H, Oikawa O, Okada K, Kikuchi F, Soma M. Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trial. Nutrients 2014;6:5992-6004. [PMID: 25533009 DOI: 10.3390/nu6125992] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
10 Kraus WE, Pieper CF, Huffman KM, Thompson DK, Kraus VB, Morey MC, Cohen HJ, Ravussin E, Redman LM, Bain JR, Stevens RD, Newgard CB. Association of Plasma Small-Molecule Intermediate Metabolites With Age and Body Mass Index Across Six Diverse Study Populations. J Gerontol A Biol Sci Med Sci 2016;71:1507-13. [PMID: 26984390 DOI: 10.1093/gerona/glw031] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kobayashi H, Abe M, Okada K, Tei R, Maruyama N, Kikuchi F, Higuchi T, Soma M. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis. Nutrients 2015;7:3783-95. [PMID: 25988769 DOI: 10.3390/nu7053783] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
12 Arkouche W, Giaime P, Mercadal L; les membres de la commission de dialyse de la Société de néphrologie. [Fluid overload and arterial hypertension in hemodialysis patients]. Nephrol Ther 2013;9:408-15. [PMID: 23953783 DOI: 10.1016/j.nephro.2013.04.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Sgambat K, Frank L, Ellini A, Sable C, Moudgil A. Carnitine supplementation improves cardiac strain rate in children on chronic hemodialysis. Pediatr Nephrol 2012;27:1381-7. [PMID: 22438019 DOI: 10.1007/s00467-012-2144-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mizuiri S, Nishizawa Y, Doi T, Yamashita K, Shigemoto K, Usui K, Arita M, Naito T, Doi S, Masaki T. Iron, coronary artery calcification, and mortality in patients undergoing hemodialysis. Ren Fail 2021;43:371-80. [PMID: 33596750 DOI: 10.1080/0886022X.2021.1880937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Fatouros IG, Douroudos I, Panagoutsos S, Pasadakis P, Nikolaidis MG, Chatzinikolaou A, Sovatzidis A, Michailidis Y, Jamurtas AZ, Mandalidis D, Taxildaris K, Vargemezis V. Effects of l-Carnitine on Oxidative Stress Responses in Patients with Renal Disease. Medicine & Science in Sports & Exercise 2010;42:1809-18. [DOI: 10.1249/mss.0b013e3181dbacab] [Cited by in Crossref: 41] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
16 Kamei Y, Kamei D, Tsuchiya K, Mineshima M, Nitta K. Association between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients. PLoS One 2018;13:e0201591. [PMID: 30133480 DOI: 10.1371/journal.pone.0201591] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Kamei D, Tsuchiya K, Nitta K, Mineshima M, Akiba T. Association between resistance to erythropoiesis-stimulating agents and carnitine profile in patients on maintenance haemodialysis. Nephrology (Carlton) 2018;23:737-43. [PMID: 28608940 DOI: 10.1111/nep.13079] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
18 Higuchi T, Abe M, Yamazaki T, Okawa E, Ando H, Hotta S, Oikawa O, Kikuchi F, Okada K, Soma M. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial. Am J Kidney Dis 2016;67:260-70. [PMID: 26508680 DOI: 10.1053/j.ajkd.2015.09.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
19 Reuter SE, Evans AM. Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects. Clin Pharmacokinet 2012;51:553-72. [PMID: 22804748 DOI: 10.1007/BF03261931] [Cited by in Crossref: 182] [Cited by in F6Publishing: 104] [Article Influence: 18.2] [Reference Citation Analysis]
20 Hasegawa T, Zhao J, Fuller DS, Bieber B, Zee J, Morgenstern H, Hanafusa N, Nangaku M. Erythropoietin Hyporesponsiveness in Dialysis Patients: Possible Role of Statins. Am J Nephrol 2017;46:11-7. [PMID: 28564644 DOI: 10.1159/000477217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
21 Reuter SE, Evans AM. What is the value of l ‐carnitine level determination for carnitine supplementation in hemodialysis patients? Hemodial Int 2013;17:335-8. [DOI: 10.1111/hdi.12021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Miyagawa T, Miyadera H, Tanaka S, Kawashima M, Shimada M, Honda Y, Tokunaga K, Honda M. Abnormally low serum acylcarnitine levels in narcolepsy patients. Sleep 2011;34:349-53A. [PMID: 21358852 DOI: 10.1093/sleep/34.3.349] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]